Prognostic Value of Circulating Regulatory T Cells for Worsening Heart Failure in Heart Failure Patients With Reduced Ejection Fraction

Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduce...

Full description

Saved in:
Bibliographic Details
Published inInternational Heart Journal Vol. 55; no. 3; pp. 271 - 277
Main Authors Miyauchi, Yuka, Okamoto, Naoko, Ishihara, Yasuhiro, Kohno, Masakazu, Murakami, Kazushi, Noma, Takahisa, Oomizu, Souichi, Namba, Tsunetatsu, Iwado, Yasuyoshi, Ohmori, Koji, Takabatake, Wataru, Ishizawa, Makoto, Yamaoka, Genji
Format Journal Article
LanguageEnglish
Published Japan International Heart Journal Association 2014
Subjects
Online AccessGet full text
ISSN1349-2365
1349-3299
DOI10.1536/ihj.13-343

Cover

Abstract Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduced ejection fraction (HF-REF). The study population consisted of 32 HF-REF patients who were hospitalized for worsening HF, and 18 control subjects. Cardiac function was evaluated by echocardiography. A single venous blood sample was collected before discharge. Circulating T cells were evaluated by flow cytometry. Tregs were defined as CD4+CD25+Foxp3+T cells, and the correlations between the frequency of Tregs and CRP, IL-6 and several echoparameters were analysed. Furthermore, all HF-REF patients were followed up to 12 months from discharge to examine the predictors of recurrent hospitalization. In HF-REF patients, Tregs were significantly decreased (5.9 ± 1.4 versus 8.0 ± 2.2%, P < 0.01), while CD4+HLADR+T cells were increased (10.1 ± 5.4 versus 7.3 ± 3.1%, P < 0.05), compared with controls. Tregs were negatively correlated with left ventricular end-diastolic dimension, and levels of CRP and IL-6. Eleven of 32 HF-REF patients were rehospitalized for worsening HF within 12 months. Multivariate Cox regression analysis showed that CD4/CD8 and frequency of Tregs were independent predictors for recurrent hospitalization. Furthermore, HF-REF patients expressing under 6% Treg/CD4+T cells showed a significantly higher incidence of recurrent hospitalization for worsening HF within 12 months. Our data suggest that Tregs might be involved in the pathogenesis of decompensated HF, and may be a novel predictor of poor prognosis in HF-REF patients.
AbstractList Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the pathogenesis of atherosclerosis and myocarditis. Here, we investigated the involvement of Tregs on worsening heart failure (HF) in patients with reduced ejection fraction (HF-REF). The study population consisted of 32 HF-REF patients who were hospitalized for worsening HF, and 18 control subjects. Cardiac function was evaluated by echocardiography. A single venous blood sample was collected before discharge. Circulating T cells were evaluated by flow cytometry. Tregs were defined as CD4(+)CD25(+)Foxp3(+)T cells, and the correlations between the frequency of Tregs and CRP, IL-6 and several echoparameters were analysed. Furthermore, all HF-REF patients were followed up to 12 months from discharge to examine the predictors of recurrent hospitalization.In HF-REF patients, Tregs were significantly decreased (5.9 ± 1.4 versus 8.0 ± 2.2%, P < 0.01), while CD4(+)HLADR(+)T cells were increased (10.1 ± 5.4 versus 7.3 ± 3.1%, P < 0.05), compared with controls. Tregs were negatively correlated with left ventricular end-diastolic dimension, and levels of CRP and IL-6. Eleven of 32 HF-REF patients were rehospitalized for worsening HF within 12 months. Multivariate Cox regression analysis showed that CD4/CD8 and frequency of Tregs were independent predictors for recurrent hospitalization. Furthermore, HF-REF patients expressing under 6% Treg/CD4(+)T cells showed a significantly higher incidence of recurrent hospitalization for worsening HF within 12 months.Our data suggest that Tregs might be involved in the pathogenesis of decompensated HF, and may be a novel predictor of poor prognosis in HF-REF patients.
Author Noma, Takahisa
Murakami, Kazushi
Oomizu, Souichi
Yamaoka, Genji
Okamoto, Naoko
Takabatake, Wataru
Ishizawa, Makoto
Ishihara, Yasuhiro
Ohmori, Koji
Kohno, Masakazu
Miyauchi, Yuka
Iwado, Yasuyoshi
Namba, Tsunetatsu
Author_xml – sequence: 1
  fullname: Miyauchi, Yuka
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Okamoto, Naoko
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Ishihara, Yasuhiro
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Kohno, Masakazu
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Murakami, Kazushi
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Noma, Takahisa
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Oomizu, Souichi
  organization: Department of Immunology, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Namba, Tsunetatsu
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Iwado, Yasuyoshi
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Ohmori, Koji
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Takabatake, Wataru
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Ishizawa, Makoto
  organization: Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University
– sequence: 1
  fullname: Yamaoka, Genji
  organization: Department of Clinical Laboratory, Faculty of Medicine, Kagawa University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24814327$$D View this record in MEDLINE/PubMed
BookMark eNptkM1OwzAQhC0EAlq48ADIZ6RAnE2a-AaqKEWqRIX4OUaus25dpTaynUOfgNcmaaCHisvuyP5mpJ0BOTbWICFXLL5lGYzu9Gp9yyCCFI7IOYOUR5BwfvyrExhlZ2Tg_TqOU5bF-Sk5S9KCpZDk5-R77uzSWB-0pB-ibpBaRcfayaYWQZslfcVlJ63b0jc6xrr2VFlHP63zaDpgisIFOhG6bhxSbQ4e5m0MmuDppw6rNq1qJFb0cY0yaGvoxImduCAnStQeL3_3kLxPHt_G02j28vQ8fphFMs3jEKmi4FymiSy4qJTIGTBeAVSq4hmTjBUAC5HHPGUqERJZobjgnONIJlzhQsKQXPe5X81ig1X55fRGuG3510gL3PSAdNZ7h2qPsLjs6i7buksGZVt3C8cHsNRBdPcE197_v-W-t6x9EEvcp7edaVnjDs2yErrRW_ZfciVciQZ-AE4xm-Q
CitedBy_id crossref_primary_10_3389_fimmu_2021_732794
crossref_primary_10_1155_2016_4396368
crossref_primary_10_3390_nu16040546
crossref_primary_10_7717_peerj_15893
crossref_primary_10_1161_CIRCRESAHA_116_310342
crossref_primary_10_1007_s10557_017_6752_z
crossref_primary_10_3390_ijms25052667
crossref_primary_10_1007_s11596_018_1866_5
crossref_primary_10_1097_CM9_0000000000002875
crossref_primary_10_3390_jpm10020039
crossref_primary_10_1016_j_carpath_2024_107635
crossref_primary_10_1038_s41419_018_1209_2
crossref_primary_10_1016_j_jacbts_2023_03_015
crossref_primary_10_1016_j_lfs_2022_120392
crossref_primary_10_3389_fimmu_2022_914033
crossref_primary_10_3390_biom13101535
crossref_primary_10_1016_j_pharmthera_2016_03_006
crossref_primary_10_3389_fcvm_2022_993142
crossref_primary_10_3920_BM2016_0119
crossref_primary_10_1007_s11936_018_0617_z
crossref_primary_10_1177_2047487319870344
crossref_primary_10_3390_biomedicines11041029
crossref_primary_10_3390_medicina57020176
crossref_primary_10_1155_2018_4396351
crossref_primary_10_1038_nrcardio_2015_169
crossref_primary_10_3390_biomedicines10112712
crossref_primary_10_3390_jcdd9020063
crossref_primary_10_1093_cvr_cvac142
crossref_primary_10_1002_ehf2_12744
crossref_primary_10_1111_anec_12781
crossref_primary_10_1096_fj_202400839R
crossref_primary_10_3389_fphys_2021_695047
crossref_primary_10_1186_s13287_022_03101_w
crossref_primary_10_1093_labmed_lmz049
crossref_primary_10_3892_etm_2017_4202
crossref_primary_10_1152_ajpheart_00028_2019
crossref_primary_10_1161_ATVBAHA_119_312287
crossref_primary_10_3389_fcvm_2024_1430477
Cites_doi 10.1111/j.0105-2896.2005.00231.x
10.1126/science.1160062
10.1016/j.cyto.2009.09.007
10.1016/j.jbspin.2008.08.002
10.1182/blood-2003-11-3900
10.1002/eji.201040558
10.1161/01.CIR.0000147611.92021.2B
10.1161/01.CIR.88.1.107
10.4049/jimmunol.176.8.4622
10.1007/s10741-012-9352-9
10.4049/jimmunol.155.3.1151
10.1016/j.amjcard.2005.03.006
10.1161/CIRCULATIONAHA.104.508465
10.1016/S0008-6363(03)00362-6
10.1016/j.jacc.2007.02.037
10.1016/S0140-6736(00)04560-8
10.1084/jem.20030152
10.1038/nature04753
10.1038/ni1105-1069
10.1016/j.ahj.2003.07.023
10.1056/NEJM199108013250501
10.1159/000303050
10.1161/CIRCULATIONAHA.108.832782
10.1536/ihj.52.382
10.1093/eurheartj/ehi631
ContentType Journal Article
Copyright 2014 by the International Heart Journal Association
Copyright_xml – notice: 2014 by the International Heart Journal Association
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1536/ihj.13-343
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-3299
EndPage 277
ExternalDocumentID 24814327
10_1536_ihj_13_343
article_ihj_55_3_55_13_343_article_char_en
Genre Journal Article
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
AAFWJ
ACPRK
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
OK1
RJT
RZJ
SDH
TKC
TR2
X7M
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-c470t-f8899c42c89adfa71319d33dfd951c11833ba70941f2ace18f9a999e6c29febc3
ISSN 1349-2365
IngestDate Fri Sep 17 19:08:25 EDT 2021
Thu Apr 24 22:53:51 EDT 2025
Tue Jul 01 00:56:06 EDT 2025
Wed Sep 03 06:11:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c470t-f8899c42c89adfa71319d33dfd951c11833ba70941f2ace18f9a999e6c29febc3
OpenAccessLink https://www.jstage.jst.go.jp/article/ihj/55/3/55_13-343/_article/-char/en
PMID 24814327
PageCount 7
ParticipantIDs pubmed_primary_24814327
crossref_primary_10_1536_ihj_13_343
crossref_citationtrail_10_1536_ihj_13_343
jstage_primary_article_ihj_55_3_55_13_343_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-00-00
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle International Heart Journal
PublicationTitleAlternate Int. Heart J.
PublicationYear 2014
Publisher International Heart Journal Association
Publisher_xml – name: International Heart Journal Association
References 21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90.
8. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of immune response. Immunol Rev 2005; 203: 156-64. (Review)
1. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-12.
14. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7.
22. Hori M, Sasayama S, Kitabatake A, et al; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-30.
18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
10. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76: 10-4. (Review)
23. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7.
12. Tang TT, Ding YJ, Liao YH, et al. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 2010; 25: 451-8.
5. Vaduganathan M, Greene SJ, Gheorghiade M, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013; 18: 835-45.
11. Schneider-Hohendorf T, Stenner MP, Wiendl H, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-90.
3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50.
17. Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nature Immunol 2005; 6: 1069-70.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. J Immunol 1995; 155: 1151-64.
2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subject. Circulation 1993; 88: 107-15.
15. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5.
6. Yndestad A, Holm AM, Müller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6.
19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
4. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C- 8C. (Review)
16. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622-31.
20. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185-93.
25. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
13. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12.
24. Anand IS, Latini R, Florea VG, et al; Val-HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-34.
9. Balandina A, Lécart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-41.
22
23
24
25
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 24. Anand IS, Latini R, Florea VG, et al; Val-HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-34.
– reference: 11. Schneider-Hohendorf T, Stenner MP, Wiendl H, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-90.
– reference: 5. Vaduganathan M, Greene SJ, Gheorghiade M, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013; 18: 835-45.
– reference: 15. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5.
– reference: 22. Hori M, Sasayama S, Kitabatake A, et al; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-30.
– reference: 14. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7.
– reference: 9. Balandina A, Lécart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-41.
– reference: 18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
– reference: 25. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
– reference: 4. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95: 3C- 8C. (Review)
– reference: 8. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of immune response. Immunol Rev 2005; 203: 156-64. (Review)
– reference: 12. Tang TT, Ding YJ, Liao YH, et al. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 2010; 25: 451-8.
– reference: 23. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7.
– reference: 6. Yndestad A, Holm AM, Müller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6.
– reference: 1. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-12.
– reference: 3. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-50.
– reference: 20. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185-93.
– reference: 10. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009; 76: 10-4. (Review)
– reference: 21. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-90.
– reference: 19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
– reference: 7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease. J Immunol 1995; 155: 1151-64.
– reference: 17. Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nature Immunol 2005; 6: 1069-70.
– reference: 13. Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009; 119: 2904-12.
– reference: 16. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176: 4622-31.
– reference: 2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subject. Circulation 1993; 88: 107-15.
– ident: 8
  doi: 10.1111/j.0105-2896.2005.00231.x
– ident: 15
  doi: 10.1126/science.1160062
– ident: 20
  doi: 10.1016/j.cyto.2009.09.007
– ident: 10
  doi: 10.1016/j.jbspin.2008.08.002
– ident: 9
  doi: 10.1182/blood-2003-11-3900
– ident: 11
  doi: 10.1002/eji.201040558
– ident: 1
  doi: 10.1161/01.CIR.0000147611.92021.2B
– ident: 2
  doi: 10.1161/01.CIR.88.1.107
– ident: 16
  doi: 10.4049/jimmunol.176.8.4622
– ident: 5
  doi: 10.1007/s10741-012-9352-9
– ident: 7
  doi: 10.4049/jimmunol.155.3.1151
– ident: 4
  doi: 10.1016/j.amjcard.2005.03.006
– ident: 24
  doi: 10.1161/CIRCULATIONAHA.104.508465
– ident: 6
  doi: 10.1016/S0008-6363(03)00362-6
– ident: 3
  doi: 10.1016/j.jacc.2007.02.037
– ident: 21
  doi: 10.1016/S0140-6736(00)04560-8
– ident: 18
  doi: 10.1084/jem.20030152
– ident: 19
  doi: 10.1038/nature04753
– ident: 17
  doi: 10.1038/ni1105-1069
– ident: 22
  doi: 10.1016/j.ahj.2003.07.023
– ident: 25
  doi: 10.1056/NEJM199108013250501
– ident: 12
  doi: 10.1159/000303050
– ident: 13
  doi: 10.1161/CIRCULATIONAHA.108.832782
– ident: 14
  doi: 10.1536/ihj.52.382
– ident: 23
  doi: 10.1093/eurheartj/ehi631
SSID ssj0041507
Score 2.189821
Snippet Regulatory T cells (Tregs) play a crucial role in the negative regulation of immune responses. Recent studies suggest that Tregs are involved in the...
SourceID pubmed
crossref
jstage
SourceType Index Database
Enrichment Source
Publisher
StartPage 271
SubjectTerms Aged
Echocardiography
Follow-Up Studies
Heart Failure - blood
Heart Failure - immunology
Heart Failure - physiopathology
Heart Ventricles - diagnostic imaging
Heart Ventricles - physiopathology
Humans
Immunity, Cellular
Inflammation
Male
Prognosis
Stroke Volume - physiology
T-Lymphocytes, Regulatory - immunology
Ventricular Function, Left
Title Prognostic Value of Circulating Regulatory T Cells for Worsening Heart Failure in Heart Failure Patients With Reduced Ejection Fraction
URI https://www.jstage.jst.go.jp/article/ihj/55/3/55_13-343/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/24814327
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX International Heart Journal, 2014, Vol.55(3), pp.271-277
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1349-3299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041507
  issn: 1349-2365
  databaseCode: KQ8
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 1349-3299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041507
  issn: 1349-2365
  databaseCode: DIK
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1349-3299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041507
  issn: 1349-2365
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbKQIgXxHWUmyzBC6oyGttpkkdUraomdfShQ32LbMdRs1YNapMH9gf4mfwVji-5dJvQgBercly7yffVPufkXBD6mDIZqkhSb5gFxGOCxB4HPcQLs9AXYhQzIfQb3dn5aHrBzpbBstf71fFaqkpxIq9ujSv5F1ShD3DVUbJ_gWwzKXTAZ8AXWkAY2jthPN8V2k9O51z9xjeVUf_H-U6aklzGrc4Umtev0ReDsdpsTPIFbSDfK2MPmQLPy8GE59o5fWDSXnU75jbpqvaRLVcwW1ppb4HTS2Xri092NiqiK-AeWhjtdGedezHhhz-4LsFidv9q3ZwLX9cceFPYPb9YFy1rV7lOK23G8321ynfNNR2xU9iYoz1f86uqa8XwW_vlH37WDYbaLZqy2CPUVpg4UW0fJbbUUr2v2_S_jr-0u0nboi_uvCe2jMyNoyQwtW7ylfYE9KjNJXUtNbcDPoFBSRAkVDc-TWBwUl_SsXNA1XvoPglBFNLR6MvGB4lpadxYBNwtufy5sPTnduEDienBJSgNOhvEgRJkhKHFE_TYPTn8xS7_FPXU9hl6OHN-Gs_Rz5aZ2DATFxnuMBO3zMQLbJiJgZm4YSY2EGFHRJxvr3XUzMSamdgxE9fMxDUzX6CLyeliPPVcyQ9PsnBYelkE-r9kREYxTzMe-nBCpJSmWQqagARlmFLBw2HM_IxwqfwoizmoOGokSZwpIelLdLQttuoVwvB4xSjI5ChlGZNqyKOQKBpGImWK-oL10af6sSbS5cPXZVk2idaLAQIDq4Wzjz40Y7_bLDC3jootOs2YuxOkj44toM13CYtAlyHh6_-Y9Q16pP9s1mT4Fh2Vu0q9AyG6FO8NEaE9n89-A7R31xM
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Value+of+Circulating+Regulatory+T+Cells+for+Worsening+Heart+Failure+in+Heart+Failure+Patients+With+Reduced+Ejection+Fraction&rft.jtitle=International+Heart+Journal&rft.au=Miyauchi%2C+Yuka&rft.au=Okamoto%2C+Naoko&rft.au=Ishihara%2C+Yasuhiro&rft.au=Kohno%2C+Masakazu&rft.date=2014&rft.pub=International+Heart+Journal+Association&rft.issn=1349-2365&rft.eissn=1349-3299&rft.volume=55&rft.issue=3&rft.spage=271&rft.epage=277&rft_id=info:doi/10.1536%2Fihj.13-343&rft.externalDocID=article_ihj_55_3_55_13_343_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1349-2365&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1349-2365&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1349-2365&client=summon